 | Up a level |
Rowe, Ian A; Villanueva, Càndid; Shearer, Jessica E; Torres, Ferran; Albillos, Agustín; Genescà, Joan; Garcia-Pagan, Joan C; Tripathi, Dhiraj; Hayes, Peter C; Bosch, Jaume; Abraldes, Juan G (2023). Quantifying the benefit of non-selective beta-blockers in the prevention of hepatic decompensation: a Bayesian re-analysis of the PREDESCI trial. Hepatology, 78(2), pp. 530-539. Wolters Kluwer 10.1097/HEP.0000000000000342
Villanueva, Càndid; Albillos, Agustín; Genescà, Joan; Garcia-Pagan, Joan C; Brujats, Anna; Calleja, José L; Aracil, Carles; Bañares, Rafael; Morillas, Rosa M; Poca, María; Peñas, Beatriz; Augustin, Salvador; Abraldes, Juan G; Alvarado, Edilmar; Torres, Ferran; Bosch, Jaime (2021). Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. Journal of hepatology, 75(3), pp. 589-599. Elsevier 10.1016/j.jhep.2021.04.022
Villanueva, Càndid; Albillos, Agustín; Genescà, Joan; Garcia-Pagan, Joan C; Calleja, José L; Aracil, Carles; Bañares, Rafael; Morillas, Rosa M; Poca, María; Peñas, Beatriz; Augustin, Salvador; Abraldes, Juan G; Alvarado, Edilmar; Torres, Ferran; Bosch, Jaime (2019). β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. The lancet, 393(10181), pp. 1597-1608. Elsevier 10.1016/S0140-6736(18)31875-0
